North America Cough Drops Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.

The North America Cough Drops Market size is expected to reach US$ 910.14 million by 2031 from US$ 580.21 million in 2023. The market is estimated to record a CAGR of 5.8% from 2023 to 2031.

Executive Summary and North America Cough Drops Market Analysis:

The cough drops market in North America has experienced consistent growth, driven by heightened consumer awareness regarding respiratory health and a noticeable rise in cold and flu symptoms, particularly during seasonal transitions. This market features a diverse array of products, including menthol-based, herbal, and sugar-free options, which cater to a variety of consumer preferences. The US is the biggest player in the market, mainly because of its large population and substantial healthcare spending, as well as a well-established retail infrastructure. Well-known brands like Ricola, Halls (Mondelez), and Luden's are constantly experimenting, introducing new flavors and incorporating functional ingredients like vitamin C and zinc to meet consumer demands. E-commerce growth and consumer demand for natural and organic options have also contributed to product diversification and availability. Additionally, the COVID-19 pandemic heightened focus on immunity, leading to increased demand for therapeutic lozenges. With growing interest in preventive healthcare and wellness, the North America cough drops market is expected to expand steadily in the coming years.

North America Cough Drops Market Strategic Insights

Get more information on this report Request Free Sample PDF

North America Cough Drops Market Segmentation Analysis

Key segments that contributed to the derivation of the North America cough drops market analysis are product, application, and distribution channel. 

• By product, the North America cough drops market is segmented into gluten free, sugar free, and others. The sugar free held the largest share of the market in 2023.
• By application, the North America cough drops market is bifurcated into adults and children. The adults held a larger share of the market in 2023.
• By distribution channel, the North America cough drops market is bifurcated into offline and online. The offline held a larger share of the market in 2023. Furthermore, offline is sub segmented into retail pharmacies, super-market or hyper-market and hospitals pharmacies.

North America Cough Drops Market Outlook

Viral infections such as colds or influenza are among the common causes of sore throat. A sore throat can also indicate strep throat, the common cold, allergies, or other upper respiratory illnesses. According to the World Health Organization, approximately 1 billion cases of seasonal influenza are recorded every year across the globe, including 3–5 million cases of severe illness. Symptoms typically start 1–4 days after infection and persist for about a week. The common cold, flu, and seasonal allergies are widespread respiratory issues that significantly increase the demand for cough relief products as people seek immediate relief from coughing, throat irritation, and other symptoms causing discomfort. Deteriorating air quality due to rapid-paced urbanization has been a significant concern for health systems across the world, contributing to a rise in cases of respiratory illnesses. Pollutants can worsen the health conditions of asthma and bronchitis patients, leading to more frequent coughing episodes. Consequently, consumers are increasingly seeking cough drops for relief from these symptoms. The geriatric population is particularly vulnerable to respiratory disorders due to decreased immunity and pre-existing health conditions. The world's population is aging at an unparalleled rate. According to the WHO facts published in October 2022, 1 in 6 individuals worldwide would be aged 60 or more by 2030. Thus, the number of people from this age group would increase from 1 billion in 2020 to 1.4 billion by 2030; the population would rise by quadruple to 2.1 billion by 2050. Furthermore, it is anticipated that the population of those aged 80 or older will triple between 2020 and 2050, reaching 426 million. As people age, they are more likely to experience chronic illnesses that require symptom management, including the use of cough drops for relief from coughing associated with infections or chronic conditions. According to an article published in Annals of Research Hospitals in 2018, the rising prevalence of chronic lung diseases and iatrogenic immunosuppression are leading to an increase in respiratory infections in an aging population. Moreover, 2 billion people worldwide will be older than 65 years, and more than 1 billion individuals will have a preventable chronic lung disease by 2050. In response to the rising incidence of respiratory disorders, manufacturers in the cough drops market are innovating their product lines and adopting development strategies such as collaborations and partnerships to expand their businesses. Thus, the rising burden of respiratory diseases causing sore throat fuels the growth of the cough drops market across the world.

North America Cough Drops Market Country Insights

Based on country, the North America cough drops market comprises the US, Canada, and Mexico. The US held the largest share in 2023.

The US cough drops market is fueled by catering to evolving consumer preferences and increasing awareness for health and wellness. The increasing prevalence of respiratory ailments, such as colds and allergies, led to a surging demand for over-the-counter (OTC) cough and throat-soothing products. As more individuals seek effective relief from coughs and sore throats, the cough drops market has expanded to meet this demand with various flavors, formulations, and ingredients. The trend toward natural and herbal remedies is reshaping the market landscape, as consumers are becoming more health-conscious and prefer products that incorporate natural ingredients over synthetic additives. This has resulted in manufacturers innovating and launching products that feature herbal extracts, vitamins, and essential oils, appealing to the growing segment of health-aware consumers. For instance, in October 2021, HALLS, the trusted cough and throat drop brand, introduced its most convenient innovation, HALLS minis Sugar-Free Cough Drops, in collaboration with legendary sportscaster Joe Buck. E-commerce transformed cough drop purchases by increasing accessibility. Online platforms provide convenience, allowing consumers to compare products, read reviews, and access a broader range of options than traditional brick-and-mortar stores. The shift in respiratory illnesses during seasonal peaks drives up sales as consumers stock up on cough relief products. Marketing strategies emphasizing user engagement through social media and online advertisements have also played a crucial role in increasing brand visibility and attracting younger demographics to purchase cough drops online.

North America Cough Drops Market Report Highlights

North America Cough Drops Market Company Profiles

Some of the key players operating in the market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Cough Drops Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

North America Cough Drops Market Country and Regional Insights